Cargando…
Intermuscular adipose tissue in patients with systemic lupus erythematosus
OBJECTIVE: Patients with SLE frequently have debilitating fatigue and reduced physical activity. Intermuscular adipose tissue (IMAT) accumulation is associated with reduced physical exercise capacity. We hypothesised that IMAT is increased in patients with SLE and associated with increased fatigue,...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684966/ https://www.ncbi.nlm.nih.gov/pubmed/36414333 http://dx.doi.org/10.1136/lupus-2022-000756 |
_version_ | 1784835401788162048 |
---|---|
author | Gamboa, Jorge Luis Carranza-León, Daniel Crescenzi, Rachelle Pridmore, Michael Peng, Dungeng Marton, Adriana Oeser, Annette Chung, Cecilia P Titze, Jens Stein, Charles Michael Ormseth, Michelle |
author_facet | Gamboa, Jorge Luis Carranza-León, Daniel Crescenzi, Rachelle Pridmore, Michael Peng, Dungeng Marton, Adriana Oeser, Annette Chung, Cecilia P Titze, Jens Stein, Charles Michael Ormseth, Michelle |
author_sort | Gamboa, Jorge Luis |
collection | PubMed |
description | OBJECTIVE: Patients with SLE frequently have debilitating fatigue and reduced physical activity. Intermuscular adipose tissue (IMAT) accumulation is associated with reduced physical exercise capacity. We hypothesised that IMAT is increased in patients with SLE and associated with increased fatigue, reduced physical activity and increased inflammation. METHODS: In a cross-sectional study, 23 patients with SLE and 28 control participants were evaluated. IMAT was measured in the calf muscles using sequential T(1)-weighted MRI. Patient-reported physical activity and fatigue were measured and a multiplex proteomic assay was used to measure markers and mediators of inflammation. RESULTS: IMAT accumulation (percentage of IMAT area to muscle area) was significantly higher in SLE versus control participants (7.92%, 4.51%–13.39% vs 2.65%, 1.15%–4.61%, median, IQR, p<0.001) and remained significant after adjustment for age, sex, race and body mass index (p<0.001). In patients with SLE, IMAT accumulation did not differ significantly among corticosteroid users and non-users (p=0.48). In the study cohort (patients and controls), IMAT was positively correlated with self-reported fatigue score (rho=0.52, p<0.001) and inversely correlated with self-reported walking distance (rho=−0.60, p<0.001). Several markers of inflammation were associated with IMAT accumulation in patients with SLE, and gene ontology analysis showed significant enrichment for pathways associated with macrophage migration and activation in relation to IMAT. CONCLUSION: Patients with SLE have greater IMAT accumulation than controls in the calf muscles. Increased IMAT is associated with greater fatigue and lower physical activity. Future studies should evaluate the effectiveness of interventions that improve muscle quality to alleviate fatigue in patients with SLE. |
format | Online Article Text |
id | pubmed-9684966 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-96849662022-11-25 Intermuscular adipose tissue in patients with systemic lupus erythematosus Gamboa, Jorge Luis Carranza-León, Daniel Crescenzi, Rachelle Pridmore, Michael Peng, Dungeng Marton, Adriana Oeser, Annette Chung, Cecilia P Titze, Jens Stein, Charles Michael Ormseth, Michelle Lupus Sci Med Immunology and Inflammation OBJECTIVE: Patients with SLE frequently have debilitating fatigue and reduced physical activity. Intermuscular adipose tissue (IMAT) accumulation is associated with reduced physical exercise capacity. We hypothesised that IMAT is increased in patients with SLE and associated with increased fatigue, reduced physical activity and increased inflammation. METHODS: In a cross-sectional study, 23 patients with SLE and 28 control participants were evaluated. IMAT was measured in the calf muscles using sequential T(1)-weighted MRI. Patient-reported physical activity and fatigue were measured and a multiplex proteomic assay was used to measure markers and mediators of inflammation. RESULTS: IMAT accumulation (percentage of IMAT area to muscle area) was significantly higher in SLE versus control participants (7.92%, 4.51%–13.39% vs 2.65%, 1.15%–4.61%, median, IQR, p<0.001) and remained significant after adjustment for age, sex, race and body mass index (p<0.001). In patients with SLE, IMAT accumulation did not differ significantly among corticosteroid users and non-users (p=0.48). In the study cohort (patients and controls), IMAT was positively correlated with self-reported fatigue score (rho=0.52, p<0.001) and inversely correlated with self-reported walking distance (rho=−0.60, p<0.001). Several markers of inflammation were associated with IMAT accumulation in patients with SLE, and gene ontology analysis showed significant enrichment for pathways associated with macrophage migration and activation in relation to IMAT. CONCLUSION: Patients with SLE have greater IMAT accumulation than controls in the calf muscles. Increased IMAT is associated with greater fatigue and lower physical activity. Future studies should evaluate the effectiveness of interventions that improve muscle quality to alleviate fatigue in patients with SLE. BMJ Publishing Group 2022-11-22 /pmc/articles/PMC9684966/ /pubmed/36414333 http://dx.doi.org/10.1136/lupus-2022-000756 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Immunology and Inflammation Gamboa, Jorge Luis Carranza-León, Daniel Crescenzi, Rachelle Pridmore, Michael Peng, Dungeng Marton, Adriana Oeser, Annette Chung, Cecilia P Titze, Jens Stein, Charles Michael Ormseth, Michelle Intermuscular adipose tissue in patients with systemic lupus erythematosus |
title | Intermuscular adipose tissue in patients with systemic lupus erythematosus |
title_full | Intermuscular adipose tissue in patients with systemic lupus erythematosus |
title_fullStr | Intermuscular adipose tissue in patients with systemic lupus erythematosus |
title_full_unstemmed | Intermuscular adipose tissue in patients with systemic lupus erythematosus |
title_short | Intermuscular adipose tissue in patients with systemic lupus erythematosus |
title_sort | intermuscular adipose tissue in patients with systemic lupus erythematosus |
topic | Immunology and Inflammation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684966/ https://www.ncbi.nlm.nih.gov/pubmed/36414333 http://dx.doi.org/10.1136/lupus-2022-000756 |
work_keys_str_mv | AT gamboajorgeluis intermuscularadiposetissueinpatientswithsystemiclupuserythematosus AT carranzaleondaniel intermuscularadiposetissueinpatientswithsystemiclupuserythematosus AT crescenzirachelle intermuscularadiposetissueinpatientswithsystemiclupuserythematosus AT pridmoremichael intermuscularadiposetissueinpatientswithsystemiclupuserythematosus AT pengdungeng intermuscularadiposetissueinpatientswithsystemiclupuserythematosus AT martonadriana intermuscularadiposetissueinpatientswithsystemiclupuserythematosus AT oeserannette intermuscularadiposetissueinpatientswithsystemiclupuserythematosus AT chungceciliap intermuscularadiposetissueinpatientswithsystemiclupuserythematosus AT titzejens intermuscularadiposetissueinpatientswithsystemiclupuserythematosus AT steincharlesmichael intermuscularadiposetissueinpatientswithsystemiclupuserythematosus AT ormsethmichelle intermuscularadiposetissueinpatientswithsystemiclupuserythematosus |